The patient perspective on biologic DMARD dose reduction in rheumatoid arthritis: a mixed methods study-Reference-Cited by-同舟云学术

The patient perspective on biologic DMARD dose reduction in rheumatoid arthritis: a mixed methods study

Published:2018-07-13 Issue:11 Volume:57 Page:1947-1955
ISSN:1462-0324
Container-title:Rheumatology
language:en
Short-container-title:

Author:

Verhoef Lise M¹,Selten Ellen M H¹,Vriezekolk Johanna E¹,de Jong Alphons J L²,van den Hoogen Frank H J¹³,den Broeder Alfons A¹³,Hulscher Marlies E⁴

Affiliation:

1. Department of Rheumatology, Sint Maartenskliniek, Nijmegen, The Netherlands

2. Department of Rheumatology, Rijnstate, Arnhem, The Netherlands

3. Department of Rheumatology, Radboud University Medical Center, Nijmegen, The Netherlands

4. IQ Healthcare, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Link

http://academic.oup.com/rheumatology/article-pdf/57/11/1947/26146581/key205.pdf

Reference27 articles.

1. Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritis;Nam;Ann Rheum Dis,2014

2. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials;Bongartz;JAMA,2006

3. Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis;Singh;Lancet,2015

4. Down-titration and discontinuation strategies of tumor necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity;van Herwaarden;Cochrane Database Syst Rev,2014

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perspective of Dutch Patients with Gout on Continuation or Discontinuation of Urate‐Lowering Therapy During Remission: A Mixed‐Methods Study;Arthritis Care & Research;2024-07-23

2. Patients' and rheumatologists' perceptions on dose reduction of rituximab in rheumatoid arthritis;Musculoskeletal Care;2024-05

3. Patient perspectives on tapering biologic or targeted synthetic therapy in well-controlled rheumatoid arthritis and comparison with providers’ perspectives;Rheumatology;2023-10-01

4. Effect of tapered versus stable treatment with tumour necrosis factor inhibitors on disease flares in patients with rheumatoid arthritis in remission: a randomised, open label, non-inferiority trial;Annals of the Rheumatic Diseases;2023-08-22

5. Patients’ perspectives towards biologic dose reduction in psoriasis: a qualitative study;Archives of Dermatological Research;2023-02-23